Humana Reports Fourth Quarter 2020 Financial Results; Provides Full Year 2021 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Humana (HUM) PT Raised to $450 at Cantor Fitzgerald
February 3, 2021 12:30 PM ESTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $450.00 (from $440.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our OW rating on HUM and increase our price target to $450 from $440. On Wednesday, February 3, Humana reported better-than-expected 4Q20... More
Humana (HUM) Tops Q4 EPS by 6c, Offers FY21 Guidance
February 3, 2021 6:32 AM ESTHumana (NYSE: HUM) reported Q4 EPS of ($2.30), $0.06 better than the analyst estimate of ($2.36). Revenue for the quarter came in at $19.06 million versus the consensus estimate of $18.77 million.
GUIDANCE:
Humana sees FY2021 EPS of $21.25-$21.75, versus the consensus of $21.73.
For earnings history and earnings-related data on Humana (HUM) click here.
... More